Areas of Focus
- 病毒生物化学
- 病毒学
Work Experience
- 1995-09~现在 - 武汉大学 - 理学博士
- 1989-09~现在 - 同济医科大学 - 医学硕士
- 1984-09~现在 - 同济医科大学 - 医学学士
- 2020-12-25~今 - 湖北江夏实验室 - 主任
- 2018-05-08~今 - 国家重点研发计划“蛋白质机器”重点专项总体专家组 - 成员
Academic Background & Achievements
- 1995-09 理学博士: 武汉大学
- 1989-09 医学硕士: 同济医科大学
- 1984-09 医学学士: 同济医科大学
Publications
- A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in mice, 第9作者, 2024
- Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms, 第11作者, 2023
- Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB, 第5作者, 2023
- Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2, 第10作者, 2023
- High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors, 第11作者, 2023
- Regulation of the WNT-CTNNB1 signaling pathway by severe fever with thrombocytopenia syndrome virus in a cap-snatching manner, 第11作者, 2023
- CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity, 第24作者, 2022
- Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library, 第11作者, 2022
- Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2, 第9作者, 2022
- Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19, 第10作者, 2022
Awards
- 国务院政府特殊津贴 (2018): 一等奖, 国家级